We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving Immunotherapy

News   May 09, 2018 | Original story from Protagen

 
Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving Immunotherapy

Immuno-oncology: Response prediction

 
 
Advertisement
 

RELATED ARTICLES

Why Do Some People With COVID-19 Develop Severe Disease?

News

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.

READ MORE

Redesigning Existing Antibiotics To Outmanoeuver Resistant Bacteria

News

Researchers at UC San Francisco are tackling antibiotic resistance using a different approach: redesigning existing antibiotic molecules to evade a bacterium’s resistance mechanisms.

READ MORE

A Real-Time Look at How Viruses Attack at the Single-Cell Level

News

A collaboration is on a mission to understand, in visual detail and with mathematical precision, all aspects of viral attack strategies, including how viruses invade host cell protein-making machinery.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE